BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial ...
A small-diameter, defibrillation lead that can be delivered through existing commercially available catheters for targeted placement is durable and safe, with no incidence of fractures at 1 year, the ...
Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...
Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...
A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a first-in-human multicenter study. Placement of the novel UltiSynq CSP ICD ...
WASHINGTON (Sept. 16, 2019) -- Automated external defibrillators (AEDs) are often placed in areas of low risk and may be unavailable during certain times of the day. Determining the optimal location ...
Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results